|
Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome
|
Mar 2017
|
PLoS One
|
myelodysplastic syndromes (MDS)
|
|
Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia
|
Apr 2017
|
Leuk Res Rep
|
|
|
Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability.
|
May 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
Change of prognosis of patients with myelodysplastic syndromes during the last 30 years
|
Apr 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria
|
Jan 2020
|
Haematologica
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Characterization of Myelodysplastic Syndromes (MDS) With T-cell Large Granular Lymphocyte Proliferations (LGL)
|
Jun 2020
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Characterization of TP53 Mutations in Low-Grade Myelodysplastic Syndromes and Myelodysplastic Syndromes with a Non-Complex Karyotype
|
Sep 2017
|
Eur J Haematol
|
myelodysplastic syndromes (MDS)
|
|
Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study
|
Sep 2016
|
Int J Cancer
|
myelodysplastic syndromes (MDS)
|
|
Chemoimmunotherapy's potential to impact paroxysmal nocturnal hemoglobinuria
|
Feb 2012
|
Clin Adv Hematol Oncol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia
|
Oct 2019
|
Blood Advances
|
aplastic anemia
|
